Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Status and Forecast 2020-2026

Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
1.4 Market Analysis by Type
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Plasmid DNA
1.4.3 Viral Vectors
1.5 Market by Application
1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Cancers
1.5.3 Inherited Disorders
1.5.4 Viral Infections
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vectors and Plasmid DNA Manufacturing Industry Impact
1.6.1 How the Covid-19 is Affecting the Viral Vectors and Plasmid DNA Manufacturing Industry
1.6.1.1 Viral Vectors and Plasmid DNA Manufacturing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Viral Vectors and Plasmid DNA Manufacturing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Viral Vectors and Plasmid DNA Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2015-2026)
2.2 Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Regions
2.2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Viral Vectors and Plasmid DNA Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Vectors and Plasmid DNA Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Market Size
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2019
3.3 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
3.4 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
3.5 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2021-2026)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application (2015-2026)
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
6.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in North America (2019-2020)
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
7.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
8.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in China (2019-2020)
8.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
8.4 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
9.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
9.4 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
10.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
11.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in India (2019-2020)
11.3 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
11.4 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size (2015-2020)
12.2 Viral Vectors and Plasmid DNA Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 BioReliance
13.1.1 BioReliance Company Details
13.1.2 BioReliance Business Overview and Its Total Revenue
13.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
13.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020))
13.1.5 BioReliance Recent Development
13.2 Cobra Biologics
13.2.1 Cobra Biologics Company Details
13.2.2 Cobra Biologics Business Overview and Its Total Revenue
13.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
13.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.2.5 Cobra Biologics Recent Development
13.3 Oxford BioMedica
13.3.1 Oxford BioMedica Company Details
13.3.2 Oxford BioMedica Business Overview and Its Total Revenue
13.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
13.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.3.5 Oxford BioMedica Recent Development
13.4 UniQure
13.4.1 UniQure Company Details
13.4.2 UniQure Business Overview and Its Total Revenue
13.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
13.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.4.5 UniQure Recent Development
13.5 FinVector
13.5.1 FinVector Company Details
13.5.2 FinVector Business Overview and Its Total Revenue
13.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
13.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.5.5 FinVector Recent Development
13.6 MolMed
13.6.1 MolMed Company Details
13.6.2 MolMed Business Overview and Its Total Revenue
13.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
13.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.6.5 MolMed Recent Development
13.7 MassBiologics
13.7.1 MassBiologics Company Details
13.7.2 MassBiologics Business Overview and Its Total Revenue
13.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
13.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.7.5 MassBiologics Recent Development
13.8 Richter-Helm
13.8.1 Richter-Helm Company Details
13.8.2 Richter-Helm Business Overview and Its Total Revenue
13.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
13.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.8.5 Richter-Helm Recent Development
13.9 FUJIFILM Diosynth Biotechnologies
13.9.1 FUJIFILM Diosynth Biotechnologies Company Details
13.9.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
13.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
13.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
13.10 Lonza
13.10.1 Lonza Company Details
13.10.2 Lonza Business Overview and Its Total Revenue
13.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
13.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
13.10.5 Lonza Recent Development
13.11 Aldevron
10.11.1 Aldevron Company Details
10.11.2 Aldevron Business Overview and Its Total Revenue
10.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
10.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.11.5 Aldevron Recent Development
13.12 Eurogentec
10.12.1 Eurogentec Company Details
10.12.2 Eurogentec Business Overview and Its Total Revenue
10.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
10.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.12.5 Eurogentec Recent Development
13.13 Cell and Gene Therapy Catapult
10.13.1 Cell and Gene Therapy Catapult Company Details
10.13.2 Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
10.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
10.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.13.5 Cell and Gene Therapy Catapult Recent Development
13.14 Biovian
10.14.1 Biovian Company Details
10.14.2 Biovian Business Overview and Its Total Revenue
10.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
10.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.14.5 Biovian Recent Development
13.15 Brammer Bio
10.15.1 Brammer Bio Company Details
10.15.2 Brammer Bio Business Overview and Its Total Revenue
10.15.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Introduction
10.15.4 Brammer Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.15.5 Brammer Bio Recent Development
13.16 VGXI
10.16.1 VGXI Company Details
10.16.2 VGXI Business Overview and Its Total Revenue
10.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
10.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.16.5 VGXI Recent Development
13.17 PlasmidFactory
10.17.1 PlasmidFactory Company Details
10.17.2 PlasmidFactory Business Overview and Its Total Revenue
10.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
10.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
10.17.5 PlasmidFactory Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Viral Vectors and Plasmid DNA Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
Table 3. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Plasmid DNA
Table 6. Key Players of Viral Vectors
Table 7. COVID-19 Impact Global Market: (Four Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Viral Vectors and Plasmid DNA Manufacturing Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Viral Vectors and Plasmid DNA Manufacturing Players to Combat Covid-19 Impact
Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2015-2020)
Table 16. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Viral Vectors and Plasmid DNA Manufacturing Market Growth Strategy
Table 22. Main Points Interviewed from Key Viral Vectors and Plasmid DNA Manufacturing Players
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2015-2020)
Table 25. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2019)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
Table 29. Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Type (2015-2020)
Table 33. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2021-2026)
Table 34. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2015-2020)
Table 35. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 39. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 41. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 43. Europe Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 45. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 47. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 49. China Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 51. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 52. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 53. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 54. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 55. Japan Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 57. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 59. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 63. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 65. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 67. India Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 69. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 70. India Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 71. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 72. India Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Viral Vectors and Plasmid DNA Manufacturing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Viral Vectors and Plasmid DNA Manufacturing Market Share (2019-2020)
Table 75. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015-2020)
Table 77. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015-2020)
Table 79. BioReliance Company Details
Table 80. BioReliance Business Overview
Table 81. BioReliance Product
Table 82. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 83. BioReliance Recent Development
Table 84. Cobra Biologics Company Details
Table 85. Cobra Biologics Business Overview
Table 86. Cobra Biologics Product
Table 87. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 88. Cobra Biologics Recent Development
Table 89. Oxford BioMedica Company Details
Table 90. Oxford BioMedica Business Overview
Table 91. Oxford BioMedica Product
Table 92. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 93. Oxford BioMedica Recent Development
Table 94. UniQure Company Details
Table 95. UniQure Business Overview
Table 96. UniQure Product
Table 97. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 98. UniQure Recent Development
Table 99. FinVector Company Details
Table 100. FinVector Business Overview
Table 101. FinVector Product
Table 102. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 103. FinVector Recent Development
Table 104. MolMed Company Details
Table 105. MolMed Business Overview
Table 106. MolMed Product
Table 107. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 108. MolMed Recent Development
Table 109. MassBiologics Company Details
Table 110. MassBiologics Business Overview
Table 111. MassBiologics Product
Table 112. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 113. MassBiologics Recent Development
Table 114. Richter-Helm Business Overview
Table 115. Richter-Helm Product
Table 116. Richter-Helm Company Details
Table 117. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 118. Richter-Helm Recent Development
Table 119. FUJIFILM Diosynth Biotechnologies Company Details
Table 120. FUJIFILM Diosynth Biotechnologies Business Overview
Table 121. FUJIFILM Diosynth Biotechnologies Product
Table 122. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 123. FUJIFILM Diosynth Biotechnologies Recent Development
Table 124. Lonza Company Details
Table 125. Lonza Business Overview
Table 126. Lonza Product
Table 127. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 128. Lonza Recent Development
Table 129. Aldevron Company Details
Table 130. Aldevron Business Overview
Table 131. Aldevron Product
Table 132. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 133. Aldevron Recent Development
Table 134. Eurogentec Company Details
Table 135. Eurogentec Business Overview
Table 136. Eurogentec Product
Table 137. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 138. Eurogentec Recent Development
Table 139. Cell and Gene Therapy Catapult Company Details
Table 140. Cell and Gene Therapy Catapult Business Overview
Table 141. Cell and Gene Therapy Catapult Product
Table 142. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 143. Cell and Gene Therapy Catapult Recent Development
Table 144. Biovian Company Details
Table 145. Biovian Business Overview
Table 146. Biovian Product
Table 147. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 148. Biovian Recent Development
Table 149. Brammer Bio Company Details
Table 150. Brammer Bio Business Overview
Table 151. Brammer Bio Product
Table 152. Brammer Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 153. Brammer Bio Recent Development
Table 154. VGXI Company Details
Table 155. VGXI Business Overview
Table 156. VGXI Product
Table 157. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 158. VGXI Recent Development
Table 159. PlasmidFactory Company Details
Table 160. PlasmidFactory Business Overview
Table 161. PlasmidFactory Product
Table 162. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020) (Million US$)
Table 163. PlasmidFactory Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Plasmid DNA Features
Figure 3. Viral Vectors Features
Figure 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2020 VS 2026
Figure 5. Cancers Case Studies
Figure 6. Inherited Disorders Case Studies
Figure 7. Viral Infections Case Studies
Figure 8. Others Case Studies
Figure 9. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions: 2020 VS 2026
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2019
Figure 15. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2019
Figure 17. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. BioReliance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. BioReliance Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 26. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Cobra Biologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 28. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Oxford BioMedica Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 30. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. UniQure Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 32. FinVector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. FinVector Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 34. MolMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MolMed Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 36. MassBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MassBiologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 38. Richter-Helm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Richter-Helm Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 40. FUJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 42. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 44. Aldevron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Aldevron Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 46. Eurogentec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Eurogentec Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 48. Cell and Gene Therapy Catapult Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 50. Biovian Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Biovian Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 52. Brammer Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Brammer Bio Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 54. VGXI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. VGXI Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 56. PlasmidFactory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. PlasmidFactory Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs